Rollins School of Public Health | Faculty Profile
Emory Rollins School of Public Health

Neel  Gandhi

Associate Professor

Faculty, Epidemiology

Jointly Appointed, Global Health


Dr. Gandhi is an Associate Professor in the Department of Epidemiology, with secondary appointments in the Departments of Global Health and Medicine (Infectious Diseases) at the Rollins School of Public Health and Emory School of Medicine. Dr. Gandhi has been engaged in clinical research in Tuberculosis and HIV since 1998. Dr. Gandhi leads a research team focused on epidemiology, clinical and translational research studies to improve care for TB patients and create new knowledge on the factors that influence transmission and susceptibility to TB, and the emergence of drug resistance. His research group is currently engaged in molecular epidemiology and geospatial studies to identify where and what factors impact the transmission of TB. They have projects examining the safety, pharmacokinetics and molecular mechanisms of new TB drugs (e.g., bedaquiline, delamanid). Further, his group is engaged in translational studies to understand immunologic, genetic and metabolomic factors that influence whether individuals become infected with TB, if exposed, and develop active TB disease, if infected. Dr. Gandhi’s studies are currently being conducted in South Africa, Ethiopia, Brazil and India.

Contact Information

1518 Clifton Rd NE

Atlanta , GA 30322

CNR 3031

Phone: (404)727-2317

Email: neel.r.gandhi@emory.edu

Update Profile Here

Areas of Interest

  • Global Health
  • HIV/AIDS Prevention
  • Infectious Disease
  • Public Health Practice

Education

  • B.A. 1994, Williams College
  • M.D. 1999, Brown University School of Medicine
  • Fellowship 2004, Yale University
  • Fellowship 2006, Emory School of Medicine
  • Residency 2002, Columbia-Presbyterian Medical Center

Courses Taught

  • EPI 542: Epidemiology of Tuberculosis
  • GH 562: Tuberculosis

Publications

  • , , Super-bugs Threaten Global TB Control: From Extensively Drug-Resistant (XDR) to Untreatable Tuberculosis – State of the Art, Lancet Respiratory Medicine, 2, 321-338
  • , , Determination of Antiretroviral Naïve Status in Large Observational HIV Cohort, Pharmacoepi Drug Safety, 22, 1019-1025
  • , , Nosocomial spread of Extensively Drug-Resistant Tuberculosis (XDR TB) in Rural Hospital in South Africa, J Inf Dis, 207, 9-17
  • , , Integrated, Home-based Treatment Program for MDR-TB and HIV: An Alternative Approach, Int J TB Lung Dis, 16, 998-1004
  • , , Household Contact Investigation of Multidrug- and Extensively Drug-resistant Tuberculosis in a High HIV-Prevalence Setting, Int J TB Lung Dis, 15, 1170-1175
  • , , Increasing Second-line Drug Resistance Among Extensively Drug-Resistant Tuberculosis Patients in Rural South Africa, Emer Inf Dis, 17, 510-513
  • , , Rapid Diagnosis of Tuberculosis and Multidrug Resistance by the Microscopic-Observation Drug-Susceptibility Assay, Am J Resp Crit Car Med, 183, 1427-1733
  • , , HIV Co-infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality, Am J Resp Crit Car Med, 181, 80-86
  • , , Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Threat to Global Control of Tuberculosis, Lancet, 375, 1830-1843
  • , , Successful Integration of Tuberculosis and HIV Treatment in Rural South Africa: the Sizonq’oba Study, JAIDS, 50, 37-43
  • , , Delayed Presentation for HIV Care: A Problem of Access or Screening? , Medical Care, 45, 1105-1109
  • , , Development and Validation of a “Virtual” Cohort Using the National VA Health Information System, Medical Care, 44, S25-30
  • , , Extensively drug-resistant tuberculosis as a cause of death among patients co-infected with tuberculosis and HIV in a rural area in South Africa, Lancet, 368, 1575-1580
  • , , HIV Screening in Active Tuberculosis Patients in Rural Gujurat, India, Int J STD AIDS, 12, 415-416